Cargando…

Botulinum toxin type A for genitofemoral neuralgia: A case report

Genitofemoral neuralgia is an uncommon pain disorder that could be resistant to conventional treatment. A 78-year-old woman with refractory right genitofemoral neuralgia was treated with BoNT/A subcutaneous injections; the treatment was performed three times with significant pain improvement, althou...

Descripción completa

Detalles Bibliográficos
Autores principales: Tereshko, Yan, Enrico, Belgrado, Christian, Lettieri, Dal Bello, Simone, Merlino, Giovanni, Gigli, Gian Luigi, Valente, Mariarosaria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350489/
https://www.ncbi.nlm.nih.gov/pubmed/37465764
http://dx.doi.org/10.3389/fneur.2023.1228098
_version_ 1785074143044042752
author Tereshko, Yan
Enrico, Belgrado
Christian, Lettieri
Dal Bello, Simone
Merlino, Giovanni
Gigli, Gian Luigi
Valente, Mariarosaria
author_facet Tereshko, Yan
Enrico, Belgrado
Christian, Lettieri
Dal Bello, Simone
Merlino, Giovanni
Gigli, Gian Luigi
Valente, Mariarosaria
author_sort Tereshko, Yan
collection PubMed
description Genitofemoral neuralgia is an uncommon pain disorder that could be resistant to conventional treatment. A 78-year-old woman with refractory right genitofemoral neuralgia was treated with BoNT/A subcutaneous injections; the treatment was performed three times with significant pain improvement, although temporary, and without adverse events. BoNT/A may be a promising alternative intervention in the setting of genitofemoral neuralgia refractory to oral and/or topical treatment.
format Online
Article
Text
id pubmed-10350489
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-103504892023-07-18 Botulinum toxin type A for genitofemoral neuralgia: A case report Tereshko, Yan Enrico, Belgrado Christian, Lettieri Dal Bello, Simone Merlino, Giovanni Gigli, Gian Luigi Valente, Mariarosaria Front Neurol Neurology Genitofemoral neuralgia is an uncommon pain disorder that could be resistant to conventional treatment. A 78-year-old woman with refractory right genitofemoral neuralgia was treated with BoNT/A subcutaneous injections; the treatment was performed three times with significant pain improvement, although temporary, and without adverse events. BoNT/A may be a promising alternative intervention in the setting of genitofemoral neuralgia refractory to oral and/or topical treatment. Frontiers Media S.A. 2023-07-03 /pmc/articles/PMC10350489/ /pubmed/37465764 http://dx.doi.org/10.3389/fneur.2023.1228098 Text en Copyright © 2023 Tereshko, Enrico, Christian, Dal Bello, Merlino, Gigli and Valente. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Tereshko, Yan
Enrico, Belgrado
Christian, Lettieri
Dal Bello, Simone
Merlino, Giovanni
Gigli, Gian Luigi
Valente, Mariarosaria
Botulinum toxin type A for genitofemoral neuralgia: A case report
title Botulinum toxin type A for genitofemoral neuralgia: A case report
title_full Botulinum toxin type A for genitofemoral neuralgia: A case report
title_fullStr Botulinum toxin type A for genitofemoral neuralgia: A case report
title_full_unstemmed Botulinum toxin type A for genitofemoral neuralgia: A case report
title_short Botulinum toxin type A for genitofemoral neuralgia: A case report
title_sort botulinum toxin type a for genitofemoral neuralgia: a case report
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350489/
https://www.ncbi.nlm.nih.gov/pubmed/37465764
http://dx.doi.org/10.3389/fneur.2023.1228098
work_keys_str_mv AT tereshkoyan botulinumtoxintypeaforgenitofemoralneuralgiaacasereport
AT enricobelgrado botulinumtoxintypeaforgenitofemoralneuralgiaacasereport
AT christianlettieri botulinumtoxintypeaforgenitofemoralneuralgiaacasereport
AT dalbellosimone botulinumtoxintypeaforgenitofemoralneuralgiaacasereport
AT merlinogiovanni botulinumtoxintypeaforgenitofemoralneuralgiaacasereport
AT gigligianluigi botulinumtoxintypeaforgenitofemoralneuralgiaacasereport
AT valentemariarosaria botulinumtoxintypeaforgenitofemoralneuralgiaacasereport